Swaytha Vasuma Yalamanchi, MD

Offices

1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Hospitals listed: 757662 · Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plans that list them

18 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yalamanchi’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

18 of 18 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Sutter Advantage +More (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
DualConnect (HMO D-SNP)	Santa Clara Family Health Plan	Listed	Sep 1, 2026

California Medical Board record

Licence A157214 · Current

Licensed to practise in California · since 2018 · expires 2028-07-31 · Wayne State University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025

See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Peninsula Medical Center

Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.139	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.242	Better	Oct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.21 (0.27 to 2.15) · 1,258 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.81 (0.51 to 1.1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	155.44 (112.67 to 198.21) · 90 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	2.5 · 32 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	7.1 · 82 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	10 · 188 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	9 · 473 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	14.8 · 342 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	9.4 · 485 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.9 · 3,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.2 (0 to 0.4) · 6,904 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.21 (0.02 to 0.4) · 7,052 cases	No different	Jul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	3.41 (1.43 to 5.39) · 1,695 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	1.72 (0.17 to 3.28) · 665 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.11 (0.66 to 3.56) · 1,545 cases	No different	Jul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths	7.1 (1.3 to 12.9) · 670 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.96 (2.63 to 9.29) · 653 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.61 (0.15 to 3.08) · 418 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.14 (0 to 0.78) · 5,539 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.7 · 192 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.215	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.263	No different	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.74	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	14.3 · 300 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	19 · 702 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	1.2 · 207 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-13.6 · 531 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	24.3 · 343 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	18.1 · 449 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	4.5 (2.8 to 7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	9.6 (6.7 to 13.7) · 85 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.7 · 189 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	11 · 45 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	20.6 · 117 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	13 (9.7 to 17.2) · 584 cases	No different	Jan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.9 (0.7 to 1.2) · 764 cases	No different	Jan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Sort by

Patient survey stars by topic at Peninsula Medical Center

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	3
Recommend hospital	5

Sort by

Share of patients giving the best answer at Peninsula Medical Center

Room was "always" clean	76%
Nurses "always" communicated well	81%
Doctors "always" communicated well	80%
Staff "always" explained	58%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	87%
Doctors "always" explained things so they could understand	74%
Doctors "always" listened carefully	79%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	75%
Staff "always" explained new medications	72%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	54%
"YES", patients would definitely recommend the hospital	78%
Staff "always" explained possible side effects	44%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$384,093

Medicare paid this office $384,093 for 703 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Injection, romosozumab-aqqg, 1 mg	25	$174,966	None
Return visit (30+ min)	558	$91,524	$107
Injection, denosumab, 1 mg	33	$70,040	None
New patient visit (60+ min)	87	$16,074	$185
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	468	$8,623	$15

See all 10 services

Sort by

Every Original Medicare service billed

Injection, romosozumab-aqqg, 1 mg	25	$174,966	None
Return visit (30+ min)	558	$91,524	$107
Injection, denosumab, 1 mg	33	$70,040	None
New patient visit (60+ min)	87	$16,074	$185
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	468	$8,623	$15
Short return visit (20+ min)	91	$8,078	$80
Long return visit (40+ min)	29	$4,138	$143
Injection of drug or substance under skin or into muscle	58	$3,615	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	71	$3,314	$29
New patient visit (45+ min)	15	$2,227	$148

Who their Medicare patients are

703 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 17% · Women 78% · Also on Medicaid 6% · Health risk score 1.02. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 58% · Diabetes 29% · Chronic kidney disease 23% · Coronary heart disease 22% · Cancer 17% · Depression 16% · Atrial fibrillation 15% · Heart failure 9% · COPD 7% · Dementia 5% · Stroke 3%.

The office billed $1,206,642, Medicare allowed $504,766 and paid $384,093; for 25,855 services of 16 kinds; $245,500 of it was for drugs given in the office and $138,593 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	703	25,855	77	1.02	$1,206,642	$384,093
2023	620	27,966	77	1.01	$1,125,934	$373,162
2022	605	32,676	77	1.06	$1,168,626	$389,254
2021	515	8,792	77	1.02	$569,408	$194,367
2020	356	4,741	76	1.23	$339,554	$115,522
2019	368	3,454	75	1.22	$507,707	$156,705
2018	283	448	70	1.56	$126,420	$36,673
2017	221	342	68	1.95	$81,544	$27,192
2016	103	136	66	1.53	$32,667	$12,905

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Sort by

Original Medicare services billed in 2023

Injection, romosozumab-aqqg, 1 mg	25	$181,210	None
Return visit (30+ min)	476	$84,969	$113
Injection, denosumab, 1 mg	28	$53,734	None
New patient visit (60+ min)	77	$14,947	$194
Short return visit (20+ min)	115	$8,849	$68
Long return visit (40+ min)	31	$5,632	$171
Injection of drug or substance under skin or into muscle	54	$3,855	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	57	$3,176	$30
Telephone medical discussion with physician, 21-30 minutes	17	$1,528	$90
Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage	16	$1,207	$75
Administration of influenza virus vaccine	18	$680	$38

2022: 13 services

Sort by

Original Medicare services billed in 2022

Injection, romosozumab-aqqg, 1 mg	22	$212,912	None
Return visit (30+ min)	395	$64,370	$110
Injection, denosumab, 1 mg	32	$47,667	None
New patient visit (60+ min)	108	$20,001	$185
Short return visit (20+ min)	189	$17,375	$80
New patient visit (45+ min)	35	$5,011	$143
Long return visit (40+ min)	24	$3,782	$151
Injection of drug or substance under skin or into muscle	57	$3,109	$14
Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage	39	$2,740	$70
Administration of influenza virus vaccine	47	$1,775	$38
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	30	$1,715	$31
Telephone medical discussion with physician, 21-30 minutes	16	$1,664	$104
Blood glucose (sugar) test performed by hand-held instrument	11	$48	$3

2021: 11 services

Sort by

Original Medicare services billed in 2021

Return visit (30+ min)	326	$57,726	$115
Injection, denosumab, 1 mg	27	$41,586	None
New patient visit (60+ min)	156	$31,653	$203
New patient visit (45+ min)	52	$7,651	$147
Short return visit (20+ min)	70	$6,196	$82
Telephone medical discussion with physician, 21-30 minutes	34	$3,392	$85
Long return visit (40+ min)	17	$2,673	$157
Influenza vaccine split virus, preservative free	26	$1,697	$65
Injection of drug or substance under skin or into muscle	35	$1,119	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	14	$827	$33
Administration of influenza virus vaccine	28	$612	$22

2020: 9 services

Sort by

Original Medicare services billed in 2020

Injection, denosumab, 1 mg	25	$39,266	None
Return visit (30+ min)	237	$33,617	$93
New patient visit (45+ min)	113	$16,286	$144
Telephone medical discussion with physician, 11-20 minutes	86	$7,526	$70
Long return visit (40+ min)	17	$2,145	$126
Telephone medical discussion with physician, 21-30 minutes	15	$1,685	$105
Telephone medical discussion with physician, 5-10 minutes	22	$1,148	$41
Injection of drug or substance under skin or into muscle	28	$759	$14
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	14	$637	$29

2019: 7 services

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	245	$44,517	$96
Injection, denosumab, 1 mg	25	$31,862	None
New patient visit (45+ min)	155	$22,292	$144
Long return visit (40+ min)	80	$8,986	$112
Short return visit (20+ min)	21	$1,308	$57
Injection of drug or substance under skin or into muscle	27	$885	$17
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	21	$885	$33

2018: 8 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	91	$9,155	$92
Return visit (30+ min)	89	$5,220	$54
New patient visit (45+ min)	35	$4,960	$142
New patient visit (60+ min)	26	$4,279	$165
New patient visit (60+ min)	30	$4,236	$141
Long return visit (40+ min)	28	$2,483	$86
Long return visit (40+ min)	18	$2,054	$114
Hemoglobin a1c level	15	$223	$12

2017: 6 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	47	$6,439	$83
Return visit (30+ min)	73	$5,174	$59
New patient visit (45+ min)	34	$4,437	$131
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes	35	$3,819	$109
New patient visit (45+ min)	27	$2,916	$108
Hemoglobin a1c level	28	$525	$13

2016: 5 services

Sort by

Original Medicare services billed in 2016

New patient visit (45+ min)	26	$3,597	$138
Return visit (30+ min)	22	$1,434	$65
Long return visit (40+ min)	15	$1,385	$92
Return visit (30+ min)	14	$1,306	$87
Hemoglobin a1c level	17	$211	$12

Medicaid work

$353 in 2023

Medicaid paid $353 for 14 billed services this clinician did in 2023, up to 14 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2023

Return visit (30+ min)	14	$353

Sort by

Medicaid work by year

2023	14	1	14	$353

Drugs they prescribed that Part D paid

$1,327,873

Pharmacies billed $1,327,873 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 3,141) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

1,899 generic and 1,172 brand-name prescriptions · $1,327,873 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Jardiance	263	$344,451	$1,310
Ozempic	203	$292,726	$1,442
Trulicity	72	$132,373	$1,839
Mounjaro	84	$118,746	$1,414
Januvia	42	$63,003	$1,500

See all 44 drugs

Sort by

Every Part D drug this clinician prescribed

Jardiance	263	$344,451	$1,310
Ozempic	203	$292,726	$1,442
Trulicity	72	$132,373	$1,839
Mounjaro	84	$118,746	$1,414
Januvia	42	$63,003	$1,500
Farxiga	29	$48,613	$1,676
Tymlos	13	$46,226	$3,556
Rybelsus	19	$34,432	$1,812
Tresiba Flextouch U-100	55	$25,371	$461
Teriparatide	11	$23,673	$2,152
Vascepa	24	$12,555	$523
Fiasp Flextouch	13	$8,957	$689
Lyumjev Kwikpen U-100	11	$8,847	$804
Risedronate	77	$7,304	$95
Potassium Citrate Er	58	$6,850	$118
Icosapent Ethyl	27	$6,583	$244
Synthroid	52	$5,486	$105
Cinacalcet	15	$4,623	$308
Alendronate	406	$4,045	$10
Humalog	14	$3,535	$253
Levothyroxine	273	$3,455	$13
Ultra-Fine Mini Pen Needle	24	$3,370	$140
Humalog Kwikpen U-100	18	$3,152	$175
Metformin Hcl Er	182	$2,862	$16
Nano 2nd Gen Pen Needle	26	$2,856	$110
Atorvastatin	150	$2,408	$16
Hydrocortisone	34	$2,071	$61
Metformin	143	$1,538	$11
Novolog Flexpen	11	$1,373	$125
Rosuvastatin	71	$1,229	$17
Ezetimibe	25	$1,061	$42
Glipizide Er	53	$901	$17
Methimazole	74	$742	$10
Lisinopril	48	$436	$9
Amlodipine Besylate	44	$402	$9
Glimepiride	50	$305	$6
Raloxifene	12	$295	$25
Repaglinide	15	$268	$18
Hydrochlorothiazide	44	$96	$2
Pioglitazone	14	$91	$6
Gabapentin	12	$85	$7
Omeprazole	14	$84	$6
Glipizide	11	$51	$5
Dexamethasone	13	$17	$1

Year by year

Sort by

Part D prescribing by year

2024	3,141	481	0% (0)	37%	$1,327,873
2023	2,707	429	0% (0)	40%	$1,305,399
2022	2,502	411	0% (0)	41%	$1,310,149
2021	2,227	340	0% (0)	44%	$1,137,689
2020	1,960	258	0% (0)	43%	$838,856
2019	1,256	233	0% (0)	49%	$687,822
2018	611	144	0% (0)	44%	$270,461
2017	626	118	None	44%	$306,911
2016	264	72	0% (0)	51%	$106,430
2015	147	24	0% (0)	53%	$44,766
2014	165	27	0% (0)	None	$31,658
2013	243	25	None	21%	$14,302

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 40 drugs

Sort by

Part D drugs prescribed in 2023

Jardiance	220	$308,414	$1,402
Ozempic	193	$290,528	$1,505
Trulicity	104	$180,854	$1,739
Januvia	49	$74,171	$1,514
Mounjaro	57	$71,993	$1,263
Farxiga	38	$60,426	$1,590
Humalog Kwikpen U-100	33	$29,670	$899
Tresiba Flextouch U-200	12	$21,589	$1,799
Tresiba Flextouch U-100	49	$20,511	$419
Vascepa	16	$13,850	$866
Novolog Flexpen	20	$10,434	$522
Risedronate	61	$8,974	$147
Toujeo Solostar	13	$7,084	$545
Alendronate	396	$5,526	$14
Cinacalcet	17	$5,287	$311
Synthroid	41	$5,109	$125
Potassium Citrate Er	32	$4,533	$142
Metformin Hcl Er	161	$4,096	$25
Levothyroxine	235	$4,080	$17
Ultra-Fine Mini Pen Needle	25	$3,811	$152
Nano 2nd Gen Pen Needle	26	$3,582	$138
Metformin	120	$1,837	$15
Rosuvastatin	39	$1,610	$41
Atorvastatin	79	$1,314	$17
Glipizide Er	46	$1,238	$27
Methimazole	57	$970	$17
Lisinopril	43	$906	$21
Glimepiride	48	$793	$17
Raloxifene	12	$768	$64
Amlodipine Besylate	46	$705	$15
Hydrocortisone	13	$629	$48
Chlorthalidone	12	$453	$38
Gabapentin	14	$391	$28
Valsartan	14	$378	$27
Glipizide	21	$276	$13
Prednisone	15	$232	$15
Amiloride	12	$223	$19
Simvastatin	11	$213	$19
Hydrochlorothiazide	29	$121	$4
Dexamethasone	12	$10	$1

2022: 41 drugs

Sort by

Part D drugs prescribed in 2022

Trulicity	170	$271,667	$1,598
Jardiance	171	$251,255	$1,469
Ozempic	115	$193,573	$1,683
Januvia	61	$87,059	$1,427
Forteo	18	$77,784	$4,321
Tymlos	22	$53,528	$2,433
Farxiga	31	$37,061	$1,196
Tresiba Flextouch U-200	18	$36,155	$2,009
Humalog Kwikpen U-100	16	$23,499	$1,469
Vascepa	29	$19,512	$673
Novolog Flexpen	24	$19,415	$809
Tresiba Flextouch U-100	48	$17,926	$373
Risedronate	47	$14,128	$301
Humalog	13	$12,879	$991
Novolog	13	$12,214	$940
Lantus Solostar	17	$9,005	$530
Tresiba	11	$8,481	$771
Alendronate	340	$7,353	$22
Potassium Citrate Er	25	$4,063	$163
Metformin Hcl Er	182	$3,859	$21
Levothyroxine	179	$3,300	$18
Synthroid	25	$2,777	$111
Nano 2nd Gen Pen Needle	19	$2,510	$132
Rosuvastatin	46	$2,145	$47
Ultra-Fine Mini Pen Needle	18	$2,118	$118
Cinacalcet	14	$1,763	$126
Atorvastatin	68	$1,259	$19
Raloxifene	12	$1,256	$105
Ezetimibe	16	$1,208	$76
Glipizide Er	44	$1,153	$26
Metformin	109	$1,102	$10
Repaglinide	18	$661	$37
Methimazole	35	$625	$18
Glipizide	34	$604	$18
Amlodipine Besylate	40	$580	$15
Glimepiride	46	$477	$10
Lisinopril	53	$468	$9
Prednisone	16	$223	$14
Hydrochlorothiazide	32	$131	$4
Gabapentin	12	$112	$9
Dexamethasone	13	$10	$1

2021: 40 drugs

Sort by

Part D drugs prescribed in 2021

Trulicity	214	$289,905	$1,355
Ozempic	113	$173,383	$1,534
Jardiance	128	$167,350	$1,307
Forteo	14	$64,620	$4,616
Januvia	43	$59,088	$1,374
Tresiba Flextouch U-200	21	$40,120	$1,910
Humalog Kwikpen U-100	38	$38,368	$1,010
Tymlos	14	$33,783	$2,413
Rybelsus	24	$22,927	$955
Humalog	28	$22,153	$791
Tresiba Flextouch U-100	53	$21,508	$406
Toujeo Max Solostar	18	$20,237	$1,124
Novolog	16	$18,449	$1,153
Novolog Flexpen	15	$14,917	$994
Lantus Solostar	21	$10,594	$504
Vascepa	20	$9,562	$478
Risedronate	21	$6,753	$322
Synthroid	38	$3,980	$105
Repaglinide	26	$3,955	$152
Levothyroxine	155	$3,191	$21
Alendronate	241	$3,079	$13
Potassium Citrate Er	22	$3,079	$140
Metformin Hcl Er	124	$2,642	$21
Nano 2nd Gen Pen Needle	12	$1,942	$162
Raloxifene	12	$1,528	$127
Rosuvastatin	27	$1,436	$53
Ultra-Fine Mini Pen Needle	18	$1,434	$80
Hydrocortisone	14	$1,368	$98
Atorvastatin	60	$1,261	$21
Glipizide Er	55	$1,199	$22
Metformin	121	$1,042	$9
Methimazole	36	$826	$23
Glipizide	43	$477	$11
Glimepiride	35	$465	$13
Amlodipine Besylate	22	$234	$11
Prednisone	14	$215	$15
Gabapentin	13	$201	$15
Lisinopril	24	$74	$3
Hydrochlorothiazide	20	$40	$2
Dexamethasone	16	$24	$2

2020: 40 drugs

Sort by

Part D drugs prescribed in 2020

Trulicity	184	$213,104	$1,158
Ozempic	61	$79,158	$1,298
Jardiance	75	$79,141	$1,055
Forteo	19	$78,609	$4,137
Humalog Kwikpen U-100	42	$41,342	$984
Januvia	44	$40,748	$926
Victoza 3-Pak	27	$32,603	$1,208
Toujeo Max Solostar	22	$23,968	$1,089
Novolog	26	$23,392	$900
Tresiba Flextouch U-200	12	$19,143	$1,595
Rybelsus	16	$18,821	$1,176
Tresiba Flextouch U-100	52	$18,514	$356
Humalog	14	$16,251	$1,161
Lantus Solostar	32	$15,945	$498
Lantus	16	$13,776	$861
Basaglar Kwikpen U-100	11	$7,695	$700
Risedronate	21	$5,124	$244
Potassium Citrate Er	21	$3,763	$179
Levothyroxine	117	$2,948	$25
Repaglinide	39	$2,821	$72
Ultra-Fine Mini Pen Needle	32	$2,708	$85
Raloxifene	19	$2,521	$133
Metformin Hcl Er	121	$2,291	$19
Alendronate	177	$2,290	$13
Synthroid	24	$2,081	$87
Glipizide Er	45	$1,645	$37
Ultra-Fine Nano Pen Needle	16	$1,644	$103
Atorvastatin	70	$1,527	$22
Metformin	117	$1,316	$11
Novofine 32	15	$971	$65
Hydrocortisone	16	$882	$55
Methimazole	41	$751	$18
Glipizide	49	$631	$13
Glimepiride	28	$297	$11
Losartan	19	$271	$14
Lisinopril	19	$133	$7
Hydrochlorothiazide	23	$90	$4
Levoxyl	12	$89	$7
Amlodipine Besylate	15	$88	$6
Dexamethasone	11	$9	$1

2019: 32 drugs

Sort by

Part D drugs prescribed in 2019

Forteo	23	$131,102	$5,700
Trulicity	100	$125,738	$1,257
Januvia	61	$56,681	$929
Jardiance	52	$46,642	$897
Humalog Kwikpen U-100	37	$44,380	$1,199
Victoza 3-Pak	34	$41,607	$1,224
Humalog	25	$28,648	$1,146
Lantus	32	$22,161	$693
Ozempic	14	$19,647	$1,403
Lantus Solostar	31	$19,237	$621
Novolog	19	$17,581	$925
Basaglar Kwikpen U-100	14	$8,164	$583
Levemir Flextouch	15	$5,649	$377
Tresiba Flextouch U-100	11	$4,741	$431
Raloxifene	28	$3,937	$141
Repaglinide	33	$2,464	$75
Levothyroxine	73	$2,033	$28
Ultra-Fine Nano Pen Needle	17	$2,009	$118
Metformin Hcl Er	67	$1,748	$26
Glipizide Er	25	$1,681	$67
Synthroid	15	$1,350	$90
Atorvastatin	45	$1,293	$29
Ultra-Fine Mini Pen Needle	19	$1,242	$65
Novofine 32	13	$897	$69
Alendronate	68	$767	$11
Hydrocortisone	14	$678	$48
Metformin	77	$634	$8
Methimazole	15	$424	$28
Glipizide	27	$344	$13
Glimepiride	19	$203	$11
Hydrochlorothiazide	19	$140	$7
Lisinopril	11	$89	$8

2018: 21 drugs

Sort by

Part D drugs prescribed in 2018

Forteo	14	$52,523	$3,752
Victoza 3-Pak	30	$40,709	$1,357
Trulicity	15	$21,447	$1,430
Humalog Kwikpen U-100	14	$17,069	$1,219
Novolog Flexpen	17	$16,003	$941
Januvia	13	$13,825	$1,063
Novolog	18	$12,767	$709
Lantus Solostar	15	$12,072	$805
Lantus	14	$4,646	$332
Levothyroxine	75	$2,124	$28
Hydrocortisone	23	$1,275	$55
Synthroid	14	$854	$61
Ultra-Fine Nano Pen Needle	11	$555	$50
Metformin Hcl Er	22	$546	$25
Atorvastatin	20	$519	$26
Ultra-Fine Short Pen Needle	12	$507	$42
Metformin	27	$330	$12
Alendronate	20	$186	$9
Pravastatin	11	$171	$16
Glipizide	21	$97	$5
Hydrochlorothiazide	11	$43	$4

2017: 15 drugs

Sort by

Part D drugs prescribed in 2017

Novolog Flexpen	38	$45,409	$1,195
Victoza 3-Pak	25	$40,507	$1,620
Lantus Solostar	29	$22,161	$764
Humalog Kwikpen U-100	18	$16,871	$937
Trulicity	12	$14,597	$1,216
Januvia	11	$10,487	$953
Lantus	13	$7,008	$539
Metformin Hcl Er	72	$5,659	$79
Onglyza	12	$4,707	$392
Levothyroxine	80	$1,985	$25
Ultra-Fine Nano Pen Needle	20	$1,913	$96
Hydrocortisone	23	$1,391	$60
Atorvastatin	13	$428	$33
Metformin	29	$326	$11
Glipizide	39	$218	$6

2016: 6 drugs

Sort by

Part D drugs prescribed in 2016

Lantus Solostar	15	$12,308	$821
Glucagon Emergency Kit	17	$4,399	$259
Levothyroxine	40	$898	$22
Metformin Hcl Er	25	$553	$22
Hydrocortisone	17	$450	$26
Metformin	11	$130	$12

2015: 4 drugs

Sort by

Part D drugs prescribed in 2015

Androgel	14	$11,947	$853
Acarbose	22	$2,065	$94
Hydrocortisone	15	$404	$27
Levothyroxine	11	$387	$35

2014: 4 drugs

Sort by

Part D drugs prescribed in 2014

Androgel	14	$8,866	$633
Acarbose	34	$1,296	$38
Hydrocortisone	15	$700	$47
Levothyroxine	15	$508	$34

2013: 6 drugs

Sort by

Part D drugs prescribed in 2013

Crestor	18	$3,088	$172
Atorvastatin	18	$711	$40
Nifedical Xl	18	$652	$36
Omeprazole	15	$649	$43
Lisinopril	17	$138	$8
Hydrochlorothiazide	14	$93	$7

Money from drug and device companies

$12 in 2022

A payment is not proof that care is biased.

Sort by

Payments by company

Lilly USA	None	$12	1 payment Education · 2022-06-21 · $12

See the published payment

Sort by

Every published payment

Lilly USA	Education · 2022-06-21	None	$12

Professional record

NPI: 1649596180
Licence: CA A157214California A157214: Current · expires 2028-07-31
Trained: Wayne State University School of Medicine, 2010
Group: Sutter Bay Medical Foundation
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X)
Mailing address: 325 Distel Cir, Los Altos, CA, 94022
NPI first listed: 2010-04-08
NPI last updated: 2023-10-17
NPI record certified: 2023-10-17

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: The John Hopkins Hospital 600 North Wolfe St, Baltimore, MD, 21287 · 300 Pasteur Dr, Stanford, CA, 94305